Soraya Saïagh

940 total citations
31 papers, 682 citations indexed

About

Soraya Saïagh is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Soraya Saïagh has authored 31 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Soraya Saïagh's work include CAR-T cell therapy research (18 papers), Immunotherapy and Immune Responses (14 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Soraya Saïagh is often cited by papers focused on CAR-T cell therapy research (18 papers), Immunotherapy and Immune Responses (14 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Soraya Saïagh collaborates with scholars based in France and Canada. Soraya Saïagh's co-authors include Brigitte Dréno, Samuel Salot, Jérôme Tiollier, Anne‐Chantal Knol, Amir Khammari, Irène Philip, Marie‐Christine Pandolfino, Sylvie Négrier, Marie Rimbert and Frédéric Rolland and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Soraya Saïagh

29 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soraya Saïagh France 14 440 406 119 83 45 31 682
Yuki Nabeta Japan 12 349 0.8× 233 0.6× 206 1.7× 37 0.4× 59 1.3× 17 627
Tamara Loos Belgium 14 613 1.4× 427 1.1× 200 1.7× 59 0.7× 49 1.1× 18 1.0k
Hyun‐Jung Sohn South Korea 18 437 1.0× 332 0.8× 259 2.2× 96 1.2× 62 1.4× 48 702
Tristan Courau France 11 474 1.1× 382 0.9× 205 1.7× 24 0.3× 42 0.9× 14 813
Gaëlle Martin France 14 410 0.9× 120 0.3× 127 1.1× 46 0.6× 52 1.2× 26 684
Rebar N. Mohammed Iraq 14 312 0.7× 393 1.0× 196 1.6× 65 0.8× 38 0.8× 24 809
Isabel Mirones Spain 13 163 0.4× 124 0.3× 143 1.2× 50 0.6× 26 0.6× 22 470
Sarah Wright United Kingdom 10 106 0.2× 274 0.7× 171 1.4× 126 1.5× 35 0.8× 30 627
Anna Capsomidis United Kingdom 5 397 0.9× 381 0.9× 129 1.1× 85 1.0× 30 0.7× 7 622

Countries citing papers authored by Soraya Saïagh

Since Specialization
Citations

This map shows the geographic impact of Soraya Saïagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soraya Saïagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soraya Saïagh more than expected).

Fields of papers citing papers by Soraya Saïagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soraya Saïagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soraya Saïagh. The network helps show where Soraya Saïagh may publish in the future.

Co-authorship network of co-authors of Soraya Saïagh

This figure shows the co-authorship network connecting the top 25 collaborators of Soraya Saïagh. A scholar is included among the top collaborators of Soraya Saïagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soraya Saïagh. Soraya Saïagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dréno, Brigitte, Amir Khammari, Virginie Vignard, et al.. (2021). Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. Cancer Immunology Immunotherapy. 70(10). 3015–3030. 11 indexed citations
4.
Khammari, Amir, Jean‐Michel Nguyen, M.‐T. Leccia, et al.. (2020). Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial. Cancer Immunology Immunotherapy. 69(8). 1663–1672. 13 indexed citations
5.
Bouchet‐Delbos, Laurence, Émilie Varey, Soraya Saïagh, et al.. (2020). Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients. Transplantation. 105(4). 832–841. 11 indexed citations
6.
7.
Vivien, Régine, Soraya Saïagh, Philippe Lemarre, et al.. (2018). The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations. Cytotherapy. 20(3). 436–452. 1 indexed citations
8.
9.
Khammari, Amir, Jean‐Michel Nguyen, M. Saint‐Jean, et al.. (2015). Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients. Cancer Immunology Immunotherapy. 64(7). 805–815. 29 indexed citations
10.
Gallot, Géraldine, Soraya Saïagh, Béatrice Clemenceau, et al.. (2014). T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells. Journal of Immunotherapy. 37(3). 170–179. 42 indexed citations
11.
Zuliani, Thomas, et al.. (2013). Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy. PLoS ONE. 8(7). e70408–e70408. 49 indexed citations
12.
Knol, Anne‐Chantal, Jean‐Michel Nguyen, Marie‐Christine Pandolfino, et al.. (2012). Tissue Biomarkers in Melanoma Patients Treated with TIL. PLoS ONE. 7(12). e48729–e48729. 5 indexed citations
13.
Khammari, Amir, Jean‐Marc Limacher, Jean‐Michel Nguyen, et al.. (2012). Intra-lesional administrations of TG1042 (adenovirus expressing interferon-γ) combined with adoptive TIL transfer in patients with metastatic melanoma.. Journal of Clinical Oncology. 30(15_suppl). e19019–e19019. 2 indexed citations
14.
Pandolfino, Marie‐Christine, Soraya Saïagh, Anne‐Chantal Knol, & Brigitte Dréno. (2010). Comparison of three culture media for the establishment of melanoma cell lines. Cytotechnology. 62(5). 403–412. 15 indexed citations
15.
Khammari, Amir, Nathalie Labarrière, Virginie Vignard, et al.. (2009). Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones. Journal of Investigative Dermatology. 129(12). 2835–2842. 58 indexed citations
16.
Bennouna, Jaafar, Emmanuelle Bompas, Eve Marie Neidhardt, et al.. (2008). Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy. 57(11). 1599–1609. 208 indexed citations
17.
Knol, Anne Chantal, Fabrice Lemaı̂tre, Christelle Volteau, et al.. (2008). Absence of amplification of CD4+CD25high regulatory T cells during in vitro expansion of tumor‐infiltrating lymphocytes in melanoma patients. Experimental Dermatology. 17(5). 436–445. 5 indexed citations
18.
Salot, Samuel, Catherine Laplace, Soraya Saïagh, et al.. (2007). Large scale expansion of γ9δ2 T lymphocytes: Innacell γδ™ cell therapy product. Journal of Immunological Methods. 326(1-2). 63–75. 35 indexed citations
19.
Bompas, Emmanuelle, Eve Marie Neidhardt, Frédéric Rolland, et al.. (2006). An autologous Vγ9Vδ2 T lymphocytes cell therapy product generated by BrHPP (INNACELL Gamma Delta [IGD]) in metastatic renal cell carcinoma patients: Phase I clinical trial results. Journal of Clinical Oncology. 24(18_suppl). 2550–2550. 4 indexed citations
20.
Saïagh, Soraya, Carole Auger, Nicole Fabien, & J. C. Monier. (1994). Induction of Apoptosis in Mouse Thymocytes by Cyclosporin A: AnIn VitroStudy. Immunopharmacology and Immunotoxicology. 16(4). 553–576. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Nabeta Breakdown of academic impact, for papers by Tamara Loos Breakdown of academic impact, for papers by Hyun‐Jung Sohn Breakdown of academic impact, for papers by Tristan Courau Breakdown of academic impact, for papers by Gaëlle Martin Breakdown of academic impact, for papers by Rebar N. Mohammed Breakdown of academic impact, for papers by Isabel Mirones Breakdown of academic impact, for papers by Sarah Wright Breakdown of academic impact, for papers by Anna Capsomidis
Rankless by CCL
2026